Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3250625
Max Phase: Preclinical
Molecular Formula: C30H30ClN3O9S
Molecular Weight: 607.64
Molecule Type: Small molecule
Associated Items:
ID: ALA3250625
Max Phase: Preclinical
Molecular Formula: C30H30ClN3O9S
Molecular Weight: 607.64
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)NS(=O)(=O)c1ccc(/N=C(\C)C2=C(O)[C@H](N)[C@@H]3Cc4c(c(O)c5c(O)c(C)ccc5c4C)C(=O)[C@]3(O)C2=O)cc1.Cl
Standard InChI: InChI=1S/C30H29N3O9S.ClH/c1-12-5-10-18-13(2)19-11-20-24(31)27(37)21(28(38)30(20,40)29(39)23(19)26(36)22(18)25(12)35)14(3)32-16-6-8-17(9-7-16)43(41,42)33-15(4)34;/h5-10,20,24,35-37,40H,11,31H2,1-4H3,(H,33,34);1H/b32-14+;/t20-,24+,30+;/m0./s1
Standard InChI Key: OPEGOIGJDMDUBQ-QXGCKJDSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 607.64 | Molecular Weight (Monoisotopic): 607.1625 | AlogP: 2.29 | #Rotatable Bonds: 4 |
Polar Surface Area: 216.68 | Molecular Species: ZWITTERION | HBA: 11 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 12 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 2.90 | CX Basic pKa: 14.77 | CX LogP: 0.81 | CX LogD: -0.33 |
Aromatic Rings: 3 | Heavy Atoms: 43 | QED Weighted: 0.19 | Np Likeness Score: 0.35 |
1. Garmaise DL, Chu DT, Bernstein E, Inaba M, Stamm JM.. (1979) Synthesis and antibacterial activity of 2'-substituted chelocardin analogues., 22 (5): [PMID:379332] [10.1021/jm00191a018] |
Source(1):